Document Detail


Perioperative care of the lung transplant patient.
MedLine Citation:
PMID:  12122831     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Improvements in the perioperative management of lung transplant recipients have produced a 90% survival in the first 30 days following surgery. Detailed attention to donor organ procurement and preservation of the allograft are important in ensuring an early successful outcome. Early antibacterial administration based on donor or pretransplant cultures and antiviral therapy in CMV-negative recipients assist in avoiding early infectious complications. Development of hypoxemia or hemodynamic instability in the perioperative period requires a rapid, systematic evaluation with attention to mechanical, immunologic, or infectious causes. Nonpulmonary complications are not infrequent in lung transplant recipients.
Authors:
Alexander G Duarte; Scott Lick
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Chest surgery clinics of North America     Volume:  12     ISSN:  1052-3359     ISO Abbreviation:  Chest Surg. Clin. N. Am.     Publication Date:  2002 May 
Date Detail:
Created Date:  2002-07-18     Completed Date:  2003-01-13     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  9208495     Medline TA:  Chest Surg Clin N Am     Country:  United States    
Other Details:
Languages:  eng     Pagination:  397-416     Citation Subset:  IM    
Affiliation:
Division of Pulmonary & Critical Care Medicine, University of Texas Medical Branch, 301 University Boulevard, Galveston, TX 77555-0561, USA. aduarte@utmb.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anti-Bacterial Agents / therapeutic use
Atrial Flutter / etiology
Hemodynamics
Humans
Immunosuppressive Agents / therapeutic use
Intubation, Intratracheal / methods
Lung Transplantation / methods*
Perioperative Care / methods*
Pneumonia, Bacterial / prevention & control
Postoperative Complications / prevention & control*
Respiration, Artificial / methods
Chemical
Reg. No./Substance:
0/Anti-Bacterial Agents; 0/Immunosuppressive Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Diagnosis and management of pneumonia in the intensive care unit.
Next Document:  Pulmonary embolism.